QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (Publish Ahead of Print[PDF]) All Versions of this Article: 139/12/2393    most recent jn.109.113332v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Ho, E. Articles by Dashwood, R. H. PubMed PubMed Citation Articles by Ho, E. Articles by Dashwood, R. H.

---

Symposium: Nutrients and Epigenetic Regulation of Gene Expression

Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention^1,2

⁴ Department of Nutrition and Exercise Sciences, Oregon State University, Corvallis OR 97331 ⁵ Linus Pauling Institute, Oregon State University, Corvallis OR 97331 ⁶ Molecular and Cellular Biology Program, Oregon State University, Corvallis OR 97331 ⁷ Department of Environmental & Molecular Toxicology Oregon State University, Corvallis OR 97331

The reversible acetylation of histones is an important mechanism of gene regulation. During prostate cancer progression, specific modifications in acetylation patterns on histones are apparent. Targeting the epigenome, including the use of histone deacetylase (HDAC) inhibitors, is a novel strategy for cancer chemoprevention. Recently, drugs classified as HDAC inhibitors have shown promise in cancer clinical trials. We have previously found that sulforaphane (SFN), a compound found in cruciferous vegetables, inhibits HDAC activity in human colorectal and prostate cancer cells. Based on the similarity of SFN metabolites and other phytochemicals to known HDAC inhibitors, we previously demonstrated that sulforaphane acted as an HDAC inhibitor in the prostate, causing enhanced histone acetylation, derepression of P21 and Bax, and induction of cell cycle arrest/apoptosis, leading to cancer prevention. The ability of SFN to target aberrant acetylation patterns, in addition to effects on phase 2 enzymes, may make it an effective chemoprevention agent. These studies are important because of the potential to qualify or change recommendations for high-risk prostate cancer patients and thereby increase their survival through simple dietary choices incorporating easily accessible foods into their diets. These studies also will provide a strong scientific foundation for future large-scale human clinical intervention studies.

^* To whom correspondence should be addressed. E-mail: emily.ho{at}oregonstate.edu.

This article has been cited by other articles:

				J. B. Kirkland Niacin Status Impacts Chromatin Structure J. Nutr., December 1, 2009; 139(12): 2397 - 2401. [Abstract] [Full Text] [PDF]

				J. Zempleni, Y. C. Chew, B. Bao, V. Pestinger, and S. S. K. Wijeratne Repression of Transposable Elements by Histone Biotinylation J. Nutr., December 1, 2009; 139(12): 2389 - 2392. [Abstract] [Full Text] [PDF]

				E. Ho and J. Zempleni Overview to Symposium "Nutrients and Epigenetic Regulation of Gene Expression" J. Nutr., December 1, 2009; 139(12): 2387 - 2388. [Abstract] [Full Text] [PDF]

				P. J. Stover One-Carbon Metabolism-Genome Interactions in Folate-Associated Pathologies J. Nutr., December 1, 2009; 139(12): 2402 - 2405. [Abstract] [Full Text] [PDF]